SGMT

9.0805.61%
GW

George W. Kemble

Non-Executive Chairman

Dr. George W. Kemble, Ph.D. is Senior Scientific Advisor of CancerVax, Inc. Dr. Kemble has been the Director at Sagimet Biosciences Inc (formerly known as 3-V Biosciences, Inc.). since October 2015 and is Non-Executive Chairman since May 6, 2025 and served as its Executive Chairman of the Board since October 2022 until May 6, 2025. He had been Chief Scientific Officer Sagimet Biosciences Inc. since August 15, 2011 until October 2022. He had been Chief Executive Officer at Sagimet Biosciences Inc. (formerly known as 3-V Biosciences, Inc.) since October 2015 until October 2022. From 2001 to 2011, he held various leadership positions at MedImmune, a biologics company. Dr. Kemble was with MedImmune LLC, a subsidiary of Astra-ZenecaPLC, where he served as Senior Vice President of R&D and Head of Research. He served as Vice president of viral vaccines research and development at MedImmune, LLC, since October 19, 2004 and General Manager of California facilities since August 2004. He served as Director of Research since 1999 and Senior Director since 2002. Over the past 11 years, He has been critically involved in several programs within MedImmune, LLC including the basic mechanisms of attenuation and immunogenicity for FluMist(R) (Influenza Virus Vaccine Live, Intranasal), as well as a vaccine to prevent mental retardation and hearing loss in newborns caused by cytomegalovirus. He began his research career as a staff scientist at Aviron, which was later acquired by MedImmune, LLC. Early in his career, from 1993 until 2001, he was a research scientist at Aviron Ltd. He served as a Member of Scientific Advisory Board at Mymetics Corporation since August 2012. He served as a Director of LigoCyte Pharmaceuticals Inc. Dr. Kemble holds a bachelor of science in biology from Santa Clara University and a Ph.D from the department of microbiology and immunology at Stanford University and did his post-doctoral training at UCSF, where he worked on a number of different human viruses.

Positions